Charles Schwab Investment Management Inc Humacyte, Inc. Transaction History

Charles Schwab Investment Management Inc

$557 Billion
Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Humacyte, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 921,873 shares of HUMA stock, worth $1.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

921,873

Previous 765,253 20.47%

Holding current value

$1.51 Million

Previous $1.31 Million 47.25%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$1.15 - $2.77 $180,113 - $433,837	156,620 Added 20.47%	921,873 $1.93 Million
Q1 2025 Sep 15, 2025	SELL	$1.71 - $5.18 $267,820 - $811,291	-156,620 Reduced 16.99%	765,253 $1.31 Million
Q1 2025 May 09, 2025	SELL	$1.71 - $5.18 $17,895 - $54,208	-10,465 Reduced 1.35%	765,253 $1.31 Million
Q4 2024 Feb 06, 2025	BUY	$3.46 - $5.81 $188,224 - $316,064	54,400 Added 7.54%	775,718 $3.92 Million
Q3 2024 Nov 12, 2024	BUY	$5.11 - $9.46 $342,094 - $633,309	66,946 Added 10.23%	721,318 $3.92 Million
Q2 2024 Aug 12, 2024	BUY	$2.87 - $9.1 $518,336 - $1.64 Million	180,605 Added 38.12%	654,372 $3.14 Million
Q1 2024 May 08, 2024	SELL	$2.57 - $4.84 $44,949 - $84,651	-17,490 Reduced 3.56%	473,767 $1.47 Million
Q4 2023 Feb 06, 2024	BUY	$1.99 - $3.12 $65,260 - $102,317	32,794 Added 7.15%	491,257 $1.4 Million
Q3 2023 Nov 08, 2023	BUY	$2.75 - $4.48 $162,030 - $263,961	58,920 Added 14.75%	458,463 $1.34 Million
Q2 2023 Aug 09, 2023	BUY	$2.86 - $4.97 $9,123 - $15,854	3,190 Added 0.8%	399,543 $1.14 Million
Q1 2023 May 11, 2023	SELL	$2.11 - $3.25 $8,083 - $12,450	-3,831 Reduced 0.96%	396,353 $1.22 Million
Q4 2022 Feb 13, 2023	BUY	$2.02 - $3.62 $194,849 - $349,185	96,460 Added 31.76%	400,184 $844,000
Q3 2022 Nov 14, 2022	SELL	$1.22 - $5.14 $32,674 - $137,659	-26,782 Reduced 8.1%	303,724 $991,000
Q2 2022 Aug 15, 2022	BUY	$3.21 - $7.86 $92,653 - $226,871	28,864 Added 9.57%	330,506 $1.06 Million
Q1 2022 May 13, 2022	BUY	$4.65 - $7.4 $34,419 - $54,774	7,402 Added 2.52%	301,642 $2.13 Million
Q4 2021 Feb 11, 2022	BUY	$7.25 - $11.6 $2.13 Million - $3.41 Million	294,240 New	294,240 $2.13 Million

Others Institutions Holding HUMA

# of Institutions

166

Shares Held

54.4M

Call Options Held

1.1M

Put Options Held

808K

View Full List

About Humacyte, Inc.

Ticker HUMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,007,000
Market Cap $169M
Description
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...

More about HUMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Humacyte, Inc. Transaction History